Kaiser Foundation Health Plan of Southern California
Medicare | HMO | www.kp.org
| States: | California |
| Rank: | 2 |
| Score: | 88.1 |
| NCQA accreditation: | Yes |
Score reflects results of consumer surveys and success in preventing and treating illness compared with average plan. Here's how this plan was viewed by members and how it performed in prevention and treatment, broken down into 28 individual measures.
Need health insurance? Compare quotes from 180+ competing insurers.
How This Plan Performed (methodology)
| Getting care | 3 |
|---|---|
| Getting needed care | 3 |
| Getting needed care quickly | 3 |
| Satisfaction with physicians | 3 |
| How well doctors communicate | 4 |
| High rating of personal doctor | 3 |
| High rating of specialists | 3 |
| High rating of care received | 3 |
| Satisfaction with health plan services | 3 |
| High rating of health plan | 3 |
| Breast cancer screening | 5 |
| Colorectal cancer screening | 5 |
| Glaucoma screening | 3 |
| Evaluating mental health status | 5 |
| Evaluating physical health status | 3 |
| Flu shots for older adults | 5 |
| Pneumonia shots for older adults | 5 |
| Diabetes | 5 |
|---|---|
| Blood pressure control (130/80) | 5 |
| Blood pressure control (140/90) | 5 |
| Retinal eye exams | 5 |
| Glucose testing | 4 |
| Glucose control | 4 |
| LDL cholesterol screening | 5 |
| LDL cholesterol control | 5 |
| Monitoring kidney disease | 5 |
| Heart disease | 5 |
| Staying on beta blocker after heart attack | 5 |
| Controlling high blood pressure | 5 |
| Advising smokers to quit | 5 |
| LDL cholesterol screening | 5 |
| LDL cholesterol control | 5 |
| Mental and behavioral health | 5 |
| Depression--appropriate follow-up after diagnosis | 4 |
| Depression--adhering to medication for 12 weeks | 5 |
| Depresssion--adhering to medication for six months | 5 |
| Follow-up after hospitalization for mental illness | 4 |
| Alcohol or drug dependence treatment initiated | 2 |
| Alcohol or drug dependence treated for 30 days | 4 |
| Other treatment measures | |
| Managing risk of falls | 3 |
| Avoiding harmful drug and disease interactions | 4 |
| Avoiding high-risk medications | 3 |
| Medication for rheumatoid arthritis | 3 |
| Monitoring key long-term medications | 3 |
| Testing for osteoporosis | 3 |
| Managing osteoporosis in women after fracture | 5 |
| Spirometry testing for COPD | 2 |
| Discussing urinary incontinence | 3 |
I = Insufficient Data.
NA = Not applicable: Benefit is not offered, few members are affected, or the plan was not required to submit the data (Medicare only).
NR = Not reported: Plan did not calculate the measure or calculated it but did not report it.
Note: Apparent ties are due to rounding. Accreditation status is as of July 31, 2008.



